87

Hematology&Oncology
Sub Categories on Hematology&Oncology
Latest Articles
Researchers find new way to 'starve' prostate cancer tumors at the cellular level

Researchers find new way to 'starve' prostate cancer tumors at the cellular level

byIndiana UniversityKirk Staschke and Noah Sommers, a Ph.D. student at the IU School of Medicine, at the microscope. Credit: Kirk StaschkeNew research by a team of Indiana University School of M

Researchers find new way to 'starve' prostate cancer tumors at the cellular level

byIndiana UniversityKirk Staschke and Noah Sommers, a Ph.D. student at the IU School of Medicine, at the microscope. Credit: Kirk StaschkeNew research by a team of Indiana University School of M
Detroit cancer center unveils new device for treating liver cancer at home

Detroit cancer center unveils new device for treating liver cancer at home

by Julia CardiCredit: Unsplash/CC0 Public DomainA new device is now available for treating advanced liver cancer at home using electromagnetic waves, the Barbara Ann Karmanos Cancer Institute announce

Detroit cancer center unveils new device for treating liver cancer at home

by Julia CardiCredit: Unsplash/CC0 Public DomainA new device is now available for treating advanced liver cancer at home using electromagnetic waves, the Barbara Ann Karmanos Cancer Institute announce
Study identifies 'turncoat' cells that fight—and aid—cancer

Study identifies 'turncoat' cells that fight—and aid—cancer

by Michael Masciadrelli,Yale UniversityCirculating tumor antigen reactive T cells in patients with advanced melanoma. Credit:Nature Immunology(2024). DOI: 10.1038/s41590-024-02023-4Y

Study identifies 'turncoat' cells that fight—and aid—cancer

by Michael Masciadrelli,Yale UniversityCirculating tumor antigen reactive T cells in patients with advanced melanoma. Credit:Nature Immunology(2024). DOI: 10.1038/s41590-024-02023-4Y
Study reveals immune-modulatory mechanism of lurbinectedin in small-cell lung cancer

Study reveals immune-modulatory mechanism of lurbinectedin in small-cell lung cancer

byThe Mount Sinai HospitalLurbinectedin augments the anti-tumor immune response of PD-L1 blockade in immunocompetent SCLC models. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.x

Study reveals immune-modulatory mechanism of lurbinectedin in small-cell lung cancer

byThe Mount Sinai HospitalLurbinectedin augments the anti-tumor immune response of PD-L1 blockade in immunocompetent SCLC models. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.x